We report four cases of hyperkalemia induced by the association of spironol
actone with ACE inhibitor in geriatric patients. Over a period of one year,
four elderly patients treated for congestive heart failure with this assoc
iation were admitted to the Geriatric Ward with serious hyperkalemia. These
occurrences represented one third of all-cause severe hyperkalemia cases a
dmitted during this one-year period. A common observation in our cases was
that the dose of spironolactone employed far exceeded the recommended dosag
es. These cases illustrate that spironolactone dosage must be kept low in t
he setting of chronic congestive heart failure treatment, as well as the ne
ed for close monitoring of frail elderly patients who are given this combin
ation. (Aging Clin. Exp. Res. 12: 315-319, 2000) (C) 2000, Editrice Kurtis.